Janus Henderson Investors US’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Janus Henderson Investors US's EW Position: Q1 2017 in Review
Janus Henderson Investors US reduced its Edwards Lifesciences (EW) stake by 57% in Q1 2017, selling an estimated $125M and leaving 2,991,792 shares worth $93.8M. The position accounts for 0.08% of the portfolio, ranked #293.
Janus Henderson Investors US first reported a position in EW in Q2 2013 and has held it in 16 quarters since. The position peaked at $249M in Q3 2016. 690 funds tracked by Wall St. Rank hold EW as of Q1 2017.
- Janus Henderson Investors US held 2,991,792 shares of Edwards Lifesciences worth $93.8M as of Q1 2017.
- Janus Henderson Investors US sold 4,007,136 Edwards Lifesciences shares in Q1 2017, an estimated $125M.
- Edwards Lifesciences made up 0.08% of Janus Henderson Investors US's portfolio in Q1 2017, its #293 holding.
- Janus Henderson Investors US first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's Edwards Lifesciences position peaked at $249M in Q3 2016.
- 690 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.